Nadège Corradini - Concepedia

Author

Nadège Corradini

Also Known As

Corradini Nadège, Corradini, Nadège, Elodie Coquan, Julie Tandonnet, N Corradini, N. Corradini, Nadege Corradini, Nadège Corradini, Nadge Corradini, Nadège CORRADINI

341

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Institut Curie Institut Gustave Roussy Centre Léon Bérard Inserm Institut d’Hématologie et d’Oncologie Pédiatrique

About

Nadège Corradini is an author at Institut Curie specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	1.8K
2	Health Sciences	6	6	246
3	Public Health	3	3	85
4	Education	1	1	17
5	Social Sciences	1	1	17

Nadège Corradini

Publications

Citations

H-Index

Page 1

	Year	Citations
Platinum Compound-Related Ototoxicity in Children Patrizia Bertolini, Mathilde Lassalle, Guilaine Mercier, Journal of Pediatric Hematology/Oncology	2004	295
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial Sophie Piperno‐Neumann, Marie‐Cécile Le Deley, Françoise Rédiní, The Lancet Oncology Surgical OncologyMedicineMetronomic TherapySpinal OncologySurgery	2016	201
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma Clotilde Dumars, J Ngyuen, Aurélie Gaultier, Oncotarget Os CellsMalignant DiseaseMacrophage PolarizationTumor GrowthMedicine	2016	166
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study Birgit Geoerger, C. Michel Zwaan, Lynley V. Marshall, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaHodgkin LymphomaMedicineNon-hodgkin Lymphoma	2019	162
Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma Mathieu Chicard, Léo Colmet‐Daage, Nathalie Clément, Clinical Cancer Research	2017	154
Osteopetrosis, Lymphedema, Anhidrotic Ectodermal Dysplasia, and Immunodeficiency in a Boy and Incontinentia Pigmenti in His Mother Sophie Dupuis‐Girod, Nadège Corradini, S. Hadj‐Rabia, PEDIATRICS	2002	142
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study Nathalie Gaspar, Bob‐Valéry Occéan, Hélène Pacquement, European Journal of Cancer Surgical OncologyOsteosarcoma PatientsMedicineMetronomic TherapyMetronomic Chemotherapy	2017	138
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children Odile Oberlin, Oumaya Fawaz, Annie Rey, Journal of Clinical Oncology	2009	125
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG) Ami V. Desai, Giles Robinson, Karen Gauvain, Neuro-Oncology	2022	121
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) Michela Casanova, Bernadette Brennan, Rita Alaggio, European Journal of Cancer Tumoral PathologyMalignant DiseaseSurgical PathologyPathologyInflammatory Myofibroblastic Tumor	2020	119

Page 1